Trials that use: P-values
New to this method? Read the tutorial →
10,701 results
- EMERALDIndependent statistical analysis of Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE: primary endpoint results, effect estimate with confidence interval,…
- EMERALD-2Independent statistical analysis of A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EMERGEComplete statistical analysis of the randomized phase 3 EMERGE trial of aducanumab in early Alzheimer's disease, including CDR-SB, MMSE, ADAS-Cog 13, ADCS-ADL-MCI, MMRM methodology, confidence intervals, p-values, and trial limitations.
- EMERGEIndependent statistical analysis of Microenterprise Intervention to Reduce Sexual Risk Behaviors in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03766165).
- Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06482125).
- Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds: Complete Statistical AnalysisIndependent statistical analysis of Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds: Complete Statistical AnalysisIndependent statistical analysis of Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- EmiandMeIndependent statistical analysis of An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families: primary endpoint results, effect estimate with confidence interval, sample-size…
- EMMAIndependent statistical analysis of Extracellular Matrix Marker of Arrhythmia Risk (EMMA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00376532).
- EMMYIndependent statistical analysis of Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EMMYIndependent statistical analysis of Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Emotion Regulation Interventions for Alcohol-Related Sexual Aggression: Complete Statistical AnalysisIndependent statistical analysis of Emotion Regulation Interventions for Alcohol-Related Sexual Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03159468).
- EMPACT-MIIndependent statistical analysis of EMPACT-MI, the randomized, placebo-controlled phase 3 trial of empagliflozin 10 mg after myocardial infarction: covariate-adjusted Cox hazard ratio for heart failure hospitalisation or death, negative binomial rate ratios…
- Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): Complete Statistical AnalysisIndependent statistical analysis of Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): Complete Statistical AnalysisIndependent statistical analysis of EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EMPEROR-ReducedIndependent statistical analysis of EMPEROR-Reduced, a randomized phase 3 trial of empagliflozin versus placebo in chronic heart failure with reduced ejection fraction. Includes the registered time-to-event endpoint, Cox and mixed-effects analyses, reported…
- EMPIREIndependent statistical analysis of A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients: Complete Statistical AnalysisIndependent statistical analysis of EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients: primary endpoint results, effect estimate with confidence…
- EMPOWERIndependent statistical analysis of Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EMPOWER-MomIndependent statistical analysis of Postpartum Weight Loss for Women at Elevated Cardiovascular Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04914819).
- EMPOWER-T2DIndependent statistical analysis of EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04531176).
- EMTIndependent statistical analysis of Enhanced Community-Based Asthma Monitoring Through Novel Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05824936).
- EnACTIndependent statistical analysis of Developing and Testing the Enhancing Active Caregiver Training (EnACT) Intervention for Dementia Family Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ENACT-aMCIIndependent statistical analysis of ENgaging in Advance Care Planning Talks Group Visit Intervention for Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05282459).
- ENB-GS-TBLB for the Diagnosis of PPLs: Complete Statistical AnalysisIndependent statistical analysis of ENB-GS-TBLB for the Diagnosis of PPLs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02207478).
- Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00778648).
- ENCOREIndependent statistical analysis of A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE): primary endpoint results, effect estimate with confidence…
- ENCOREIndependent statistical analysis of Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ENCOREIndependent statistical analysis of Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ENCORE-VTIndependent statistical analysis of Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ENDEAVORIndependent statistical analysis of the ENDEAVOR phase 3 trial of carfilzomib and dexamethasone versus bortezomib and dexamethasone in relapsed multiple myeloma, including progression-free survival, overall survival, response, safety, and statistical methodology.
- ENDEAVORIndependent statistical analysis of Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle: Complete Statistical AnalysisIndependent statistical analysis of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ENDOMEDEIndependent statistical analysis of Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Endometrial Injury for Unexplained Infertility: Complete Statistical AnalysisIndependent statistical analysis of Endometrial Injury for Unexplained Infertility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02863198).
- EndoRings Colonoscopy vs Standard Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of EndoRings Colonoscopy vs Standard Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03418662).
- Endoscopic Therapy of Early Cancer in Barretts Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Endoscopic Therapy of Early Cancer in Barretts Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00217087).
- EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX: Complete Statistical AnalysisIndependent statistical analysis of EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Endothelial Bleb Response With Toric Lenses: Complete Statistical AnalysisIndependent statistical analysis of Endothelial Bleb Response With Toric Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00630305).
- Endothelial Hyperpolarization in Humans: Complete Statistical AnalysisIndependent statistical analysis of Endothelial Hyperpolarization in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00166166).
- Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: Complete Statistical AnalysisIndependent statistical analysis of Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00583050).
- ENDURANCE-2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection: primary endpoint results, effect estimate with confidence…
- ENDUREIndependent statistical analysis of A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis…
- ENERGIZEIndependent statistical analysis of A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8: primary endpoint results, effect estimate with confidence interval, sample-size…
- ENESTopIndependent statistical analysis of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01698905).
- ENESTPathIndependent statistical analysis of A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.: primary endpoint results, effect estimate…
- ENFORCEIndependent statistical analysis of A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning…